Categories: Clinical TrialNews

Data-Driven Studies: Faster and Smarter Results Delivered via Fusion eClinical Suite – OCT East Coast 2023

TORONTO, May 23, 2023 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), the premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will be exhibiting at OCT East Coast, May 23-24 in King of Prussia, PA.

The annual two-day conference provides attendees with the opportunity to partake in case studies, panel discussions and face to face networking opportunities around clinical operations, technology and innovation, and data management.

Unified eClinical Solutions and Managed Services for Small to Medium Life Science Organizations

“Axiom delivers leading and ground-breaking eClinical Solutions that change how you run your studies. Single sign-on access to every piece of data to affect the key decisions needed to guide and manage your clinical study. User friendly and robust EDC is just the beginning. EDC, RTSM, ePRO, eConsent and so much more. Axiom also provides optional technology to support unparalleled Data Analytics views, either with 24/7 On-Demand data support. This partnership and flexibility enables small to medium Biotech/Pharma/Medical Device companies to make informed, real-time decisions based on clinical, operations or PV data in order to strengthen and grow their clinical product results,” says Quinn Zarubick, VP Project Management.

Axiom invites attendees to come visit the team at Booth 5 for a chat over coffee to discuss upcoming study needs and how Fusion eClinical Suite can solve your eClinical and study operations needs.

To register for this event, please visit: https://www.arena-international.com/event/octeastcoast/

Learn more about Axiom’s Fusion eClinical Suite: https://www.axiommetrics.com/fusion-eclinical-suite/

About Axiom Real-Time Metrics
Axiom is celebrating 22 years of delivering hundreds of studies in dozens of countries. Since its founding in 2001, Axiom has delivered data-driven, powerful, and cost-effective eClinical Solutions and Services dedicated to small-to-medium life science companies. Axiom Fusion eClinical Suite is the most adaptable, Unified Platform that serves as the Connected Hub for all your Clinical Trial and operational data and reporting. Choose from 15+ unified modules on a single platform: EDC, DM, RTSM/IRT, CTMS, Inventory Management, ePRO, eConsent, Patient Portal, AE/SAE Tracking, Safety Database, Central/Local Lab, Imaging Management, eTMF, and 24/7 Project and Clinical Data Reporting. We are an embedded partner dedicated to the success of your study, offering managed services such as: Data Management, On-Demand Data Analytics, Biostatistics, Clinical Management, eTMF Management and Pharmacovigilance.

For more information, please visit https://www.axiommetrics.com

PR Contact

Nidhi Patel
pr@axiom.cc
+1 437.225.7676

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

4 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

5 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

5 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

6 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

8 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

8 hours ago